U. Lutze and B. Archenholtz, The impact of arthritis on daily life with the 43, pp.1142-1149, 2007.

L. Ehrlich-jones, J. Lee, P. Semanik, C. Cox, D. Dunlop et al., , 2011.

M. Brown, K. T. Wordsworth, and B. , Genetics of ankylosing RA, 2016.

, Age

, Gender, p.276

, Professional activity In employment Retired Other 162 (38.2%) 201 (47.4%) 61 (14.4%) 167 (70.5%) 30 (12.7%) 40 (16.8%) 329 (49.8%) 231 (34.9%) 101 (15.3%)

, Education level Primary Secondary Tertiary0%) 219 (51.3%) 131 (30.7%) 11 (4.6%) 134 (56.3%) 93 (39.1%), pp.77-88

, Disease duration (years) 13

, Disease activity DAS28(ESR) BASDAI Physician global assessment (0?10) Patient global assessment, pp.0-10

, 12) 3.03, p.45

, Treatments Corticosteroids alone NSAIDs alone Synthetic DMARDs ± corticosteroids8%) - 61 (18.7%) 252 (77.3%) 2 (0.6%) - 36 (15.1%) 15 (6.3%) 173 (72.7%)

, Data are presented as mean values (standard deviation) for continuous variables, and as 4 frequency counts (%) for categorical variables. Data were missing for some patients for all